These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 16372814)
21. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris. Sethy PK; Khandpur S; Sharma VK Indian J Dermatol Venereol Leprol; 2009; 75(5):476-82. PubMed ID: 19736426 [TBL] [Abstract][Full Text] [Related]
22. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris. Pasricha JS; Das SS Int J Dermatol; 1992 Dec; 31(12):875-7. PubMed ID: 1478770 [TBL] [Abstract][Full Text] [Related]
23. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Hari P; Bagga A; Jindal N; Srivastava RN Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598 [TBL] [Abstract][Full Text] [Related]
24. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy. Jain R; Kumar B J Dermatol; 2003 Oct; 30(10):713-8. PubMed ID: 14684952 [TBL] [Abstract][Full Text] [Related]
25. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus. Saha M; Powell AM; Bhogal B; Black MM; Groves RW Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532 [TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy. Jeffers JG; Shanley KJ; Schick RO J Am Vet Med Assoc; 1991 Jul; 199(1):77-80. PubMed ID: 1885333 [TBL] [Abstract][Full Text] [Related]
27. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Illei GG; Austin HA; Crane M; Collins L; Gourley MF; Yarboro CH; Vaughan EM; Kuroiwa T; Danning CL; Steinberg AD; Klippel JH; Balow JE; Boumpas DT Ann Intern Med; 2001 Aug; 135(4):248-57. PubMed ID: 11511139 [TBL] [Abstract][Full Text] [Related]
28. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases. Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233 [TBL] [Abstract][Full Text] [Related]
33. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris. Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479 [TBL] [Abstract][Full Text] [Related]
37. [Comparative evaluation of the treatment of pemphigus with corticosteroids and corticosteroids combined with immunosuppressive agents]. Michałowski R; Kuczyńska L Przegl Dermatol; 1981; 68(2):227-32. PubMed ID: 7029660 [No Abstract] [Full Text] [Related]
38. Factors affecting the duration of phase I of dexamethasone - cyclophosphamide pulse therapy. Nayak CS; Ray S; Thombre A; Jain M Indian J Dermatol Venereol Leprol; 2014; 80(4):296-9. PubMed ID: 25035352 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris. Sharma VK; Khandpur S Clin Exp Dermatol; 2013 Aug; 38(6):659-64. PubMed ID: 23837939 [TBL] [Abstract][Full Text] [Related]
40. Treatment of pemphigus: a local experience. Akhtar SJ; Hasan MU J Pak Med Assoc; 1998 Oct; 48(10):300-4. PubMed ID: 10087750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]